Second quarter 2025 net loss of $147.9 million, or basic loss per common share of $1.70 per share Second quarter 2025 Adjusted EBITDA with Tax Attributes of $76.5 million Company-wide cost reduction initiatives tracking ahead of plan, delivering $42 million in year-over-year operating...
Related Questions
Are there any material non‑recurring items or one‑time charges that inflated the loss?
How does the $76.5 million Adjusted EBITDA with tax attributes compare to prior quarters and to consensus estimates?
What is the primary driver behind the $147.9 million net loss in Q2 2025?
How does Calumet’s Q2 performance compare to its main competitors in the sector?
How will the net loss and cost‑reduction measures affect the company’s cash flow and balance sheet liquidity?
What is the expected impact of the net loss on the CLMT share price in the short term?
What is the market’s perception of the current valuation given the negative sentiment score of –30?
What is the outlook for profitability in the upcoming quarters and full‑year 2025 guidance?
Which cost‑reduction initiatives are delivering the $42 million YoY operating savings, and are they sustainable?
Will the company’s cost‑reduction strategy affect future capital‑expenditure plans or growth initiatives?